Verona Emerges Victorious From Second COPD Trial

Ensifentrine Will Head To FDA In First Half Of 2023

 
• By Kevin Grogan
  
Neon Light Sign Lungs Icon
• Source: Shutterstock

More from Respiratory

More from Therapy Areas